Mitigation of murine focal cerebral ischemia by the hypocretin/orexin system is associated with reduced inflammation

Stroke

Volumn 44, Issue 3, 2013, Pages 764-770

  Xiong, Xiaoxing ^a,b   White, Robin E ^a   Xu, Lijun ^a   Yang, Liya ^d   Sun, Xiaoyun ^a   Zou, Bende ^d   Pascual, Conrado ^a   Sakurai, Takeshi ^c   Giffard, Rona G ^a   Xie, Xinmin Simon ^a,d  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ZHEJIANG UNIVERSITY   (China)

^c KANAZAWA UNIVERSITY   (Japan)

^d AfaSci Inc   (United States)

Author keywords

Brain ischemia; Hypocretin; Inflammation; Neurobehavior; Orexin

Indexed keywords

ATAXIN 3; MESSENGER RNA; NEUROPROTECTIVE AGENT; OREXIN A; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MALE; MICROGLIA; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; WILD TYPE;

ANIMALS; BRAIN ISCHEMIA; CELL MOVEMENT; ENCEPHALITIS; INFARCTION, MIDDLE CEREBRAL ARTERY; INJECTIONS, INTRAVENTRICULAR; INTERLEUKIN-6; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROGLIA; MODELS, ANIMAL; NEUROPEPTIDES; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, NEUROPEPTIDE; RNA, MESSENGER; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84876298227     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.112.681700     Document Type: Article

References (34)

1. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell. 1998;92:573-585.
2. de Lecea L, Kilduff TS, Peyron C, Gao X, Foye PE, Danielson PE, et al. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci USA. 1998;95:322-327.
3. Sakurai T. The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness. Nat Rev Neurosci. 2007;8:171-181.
4. Shiuchi T, Haque MS, Okamoto S, Inoue T, Kageyama H, Lee S, et al. Hypothalamic orexin stimulates feeding-associated glucose utilization in skeletal muscle via sympathetic nervous system. Cell Metab. 2009;10:466-480.
5. Nishino S, Kanbayashi T. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system. Sleep Med Rev. 2005;9:269-310.
6. Culebras A. Cerebrovascular disease and sleep. Curr Neurol Neurosci Rep. 2004;4:164-169.
7. Rousseaux M, Muller P, Gahide I, Mottin Y, Romon M. Disorders of smell, taste, and food intake in a patient with a dorsomedial thalamic infarct. Stroke. 1996;27:2328-2330.
8. Espiner EA, Leikis R, Ferch RD, MacFarlane MR, Bonkowski JA, Frampton CM, et al. The neuro-cardio-endocrine response to acute subarachnoid haemorrhage. Clin Endocrinol (Oxf). 2002;56:629-635.
9. Payne RS, Tseng MT, Schurr A. The glucose paradox of cerebral ischemia: evidence for corticosterone involvement. Brain Res. 2003;971:9-17.
10. Ohno K, Sakurai T. Orexin neuronal circuitry: role in the regulation of sleep and wakefulness. Front Neuroendocrinol. 2008;29:70-87.
11. Xie X, Crowder TL, Yamanaka A, Morairty SR, Lewinter RD, Sakurai T, et al. GABA(B) receptor-mediated modulation of hypocretin/orexin neurones in mouse hypothalamus. J Physiol (Lond). 2006;574(pt 2):399-414.
12. Gerashchenko D, Horvath TL, Xie XS. Direct inhibition of hypocretin/ orexin neurons in the lateral hypothalamus by nociceptin/orphanin FQ blocks stress-induced analgesia in rats. Neuropharmacology. 2011;60:543-549.
13. Xie X, Wisor JP, Hara J, Crowder TL, LeWinter R, Khroyan TV, et al. Hypocretin/orexin and nociceptin/orphanin FQ coordinately regulate analgesia in a mouse model of stress-induced analgesia. J Clin Invest. 2008;118:2471-2481.
14. Thannickal TC, Moore RY, Nienhuis R, Ramanathan L, Gulyani S, Aldrich M, et al. Reduced number of hypocretin neurons in human narcolepsy. Neuron. 2000;27:469-474.
15. Peyron C, Faraco J, Rogers W, Ripley B, Overeem S, Charnay Y, et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med. 2000;6:991-997.
16. Dohi K, Ripley B, Fujiki N, Ohtaki H, Shioda S, Aruga T, et al. CSF hypocretin-1/orexin-A concentrations in patients with subarachnoid hemorrhage (SAH). Peptides. 2005;26:2339-2343.
17. Nakamachi T, Endo S, Ohtaki H, Yin L, Kenji D, Kudo Y, et al. Orexin-1 receptor expression after global ischemia in mice. Regul Pept. 2005;126:49-54.
18. Irving EA, Harrison DC, Babbs AJ, Mayes AC, Campbell CA, Hunter AJ, et al. Increased cortical expression of the orexin-1 receptor following permanent middle cerebral artery occlusion in the rat. Neurosci Lett. 2002;324:53-56.
19. Kitamura E, Hamada J, Kanazawa N, Yonekura J, Masuda R, Sakai F, et al. The effect of orexin-A on the pathological mechanism in the rat focal cerebral ischemia. Neurosci Res. 2010;68:154-157.
20. Yuan LB, Dong HL, Zhang HP, Zhao RN, Gong G, Chen XM, et al. Neuroprotective effect of orexin-A is mediated by an increase of hypoxia-inducible factor-1 activity in rat. Anesthesiology. 2011;114: 340-354.
21. Harada S, Fujita-Hamabe W, Tokuyama S. Effect of orexin-A on postischemic glucose intolerance and neuronal damage. J Pharmacol Sci. 2011;115:155-163.
22. Grossberg AJ, Zhu X, Leinninger GM, Levasseur PR, Braun TP, Myers MG Jr, et al. Inflammation-induced lethargy is mediated by suppression of orexin neuron activity. J Neurosci. 2011;31: 11376-11386.
23. Hara J, Beuckmann CT, Nambu T, Willie JT, Chemelli RM, Sinton CM, et al. Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron. 2001;30:345-354.
24. Xu L, Dayal M, Ouyang YB, Sun Y, Yang CF, Frydman J, et al. Chaperonin GroEL and its mutant D87K protect from ischemia in vivo and in vitro. Neurobiol Aging. 2006;27:562-569.
25. Han RQ, Ouyang YB, Xu L, Agrawal R, Patterson AJ, Giffard RG. Postischemic brain injury is attenuated in mice lacking the beta2-adrenergic receptor. Anesth Analg. 2009;108:280-287.
26. Xiong X, Barreto GE, Xu L, Ouyang YB, Xie X, Giffard RG. Increased brain injury and worsened neurological outcome in interleukin-4 knockout mice after transient focal cerebral ischemia. Stroke. 2011;42:2026-2032.
27. Khroyan TV, Zhang J, Yang L, Zou B, Xie J, Pascual C, et al. Rodent motor and neuropsychological behaviour measured in home cages using the integrated modular platform SmartCage™. Clin Exp Pharmacol Physiol. 2012;39:614-622.
28. Xu L, Voloboueva LA, Ouyang Y, Emery JF, Giffard RG. Overexpression of mitochondrial Hsp70/Hsp75 in rat brain protects mitochondria, reduces oxidative stress, and protects from focal ischemia. J Cereb Blood Flow Metab. 2009;29:365-374.
29. Stoll G, Jander S, Schroeter M. Inflammation and glial responses in ischemic brain lesions. Prog Neurobiol. 1998;56:149-171.
30. Sieber MW, Claus RA, Witte OW, Frahm C. Attenuated inflammatory response in aged mice brains following stroke. PLoS ONE. 2011;6:e26288.
31. Bülbül M, Tan R, Gemici B, Ongüt G, Izgüt-Uysal VN. Effect of orexin-a on ischemia-reperfusion-induced gastric damage in rats. J Gastroenterol. 2008;43:202-207.
32. Kapás L, Bohnet SG, Traynor TR, Majde JA, Szentirmai E, Magrath P, et al. Spontaneous and influenza virus-induced sleep are altered in TNF-alpha double-receptor deficient mice. J Appl Physiol. 2008;105:1187-1198.
33. Naik E, Dixit VM. Mitochondrial reactive oxygen species drive proinflammatory cytokine production. J Exp Med. 2011;208:417-420.
34. Hyun E, Ramachandran R, Hollenberg MD, Vergnolle N. Mechanisms behind the anti-inflammatory actions of insulin. Crit Rev Immunol. 2011;31:307-340.